****!!!!****!!!!*** "47:00 ...designed to inhibit the growth and persistence of bacteria and enveloped viruses on textile surfaces." "1:10:00 [Re. use of chemical disinfectants] I would like to see more research in this area and in the meantime excercise restraint." "1:11:00 resistant fungal infections"

****!!!!****

The Office of Pesticide Programs has established a self-certification program for certain product chemistry data of manufacturing-use products and end-use products produced by a non-integrated formulation system.

The Safe Drinking Water Act (SDWA) requires the U.S. Environmental Protection Agency (EPA) to conduct a review every six years of existing national primary drinking water regulations (NPDWRs) and determine which, if any, need to be revised. The purpose of the review, called the Six-Year Review,...

2020. EPA is announcing the availability of and seeking public comment on a draft guidance document

Details surrounding EPA's use of Regulations.gov and what docket materials are accessible on Reguations.gov.

{Includes discussion of some age-dependent adjustment factors (ADAFs)}

****!!!!****!!!!**** "interpretation of the statutory and regulatory language applicable to products marketed as cleaning products that claim, state or imply that they mitigate a pest." "where a claim or implication is made in connection with the sale or distribution of a cleaning product that its use will mitigate a pest, either by itself or in combination with any other substance, the product would be considered to be intended for a pesticidal purpose and would therefore be required to be registered." "This fact sheet applies to claims made on a cleaning product’s label or labeling or through other means such as web sites, advertising, promotional or sales activities and testimonial claims in connection with sale or distribution of the product. A link on a producer’s website to academic or extension research that demonstrates the pesticidal efficacy of an unregistered product would be considered a pesticidal claim."

FDA has stood up a new program to expedite the development of potentially safe and effective life-saving treatments for COVID-19.